Welcome to our dedicated page for Aflac SEC filings (Ticker: AFL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aflac Incorporated (NYSE: AFL) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Fortune 500 insurer in the direct life and supplemental health insurance industry, Aflac uses its filings to report financial results, risk factors, capital structure changes and significant events affecting its U.S. and Japan operations.
Investors can review Aflac’s periodic reports, such as annual reports on Form 10-K and quarterly reports on Form 10-Q, to understand segment performance for Aflac U.S. and Aflac Japan, trends in net earned premiums, adjusted earnings, investment income and capital position. These filings also discuss exposure to interest rate movements, foreign currency fluctuations in the yen/dollar exchange rate, regulatory developments and other risks that the company identifies as material to its business.
Current reports on Form 8-K offer more timely updates on specific events. Recent 8-K filings have covered quarterly financial results, supplemental earnings materials, investor presentations and a cybersecurity incident involving unauthorized access to Aflac’s network. Other 8-Ks describe financing arrangements, including contingent funding facilities and pre-capitalized trust securities that give Aflac the right to issue senior notes under defined conditions.
On Stock Titan, these filings are supplemented with AI-powered summaries that explain key points in clear language, helping users interpret complex sections on financial condition, liquidity, capital management and risk disclosures. The platform also surfaces relevant forms such as Form 4 insider transaction reports, proxy materials on executive and director matters, and other documents that can be important for evaluating governance and insider activity.
By using this page, readers can track Aflac’s real-time filing activity from EDGAR, quickly grasp the implications of lengthy documents through AI-generated highlights, and reference the underlying full-text filings for deeper analysis of AFL’s regulatory and financial reporting history.
Aflac Senior Executive Vice President and Chief Financial Officer Max Broden reported a sale of company stock. On February 6, 2026, he sold 13,000 shares of Aflac common stock at a weighted average price of $117.665 per share in multiple transactions priced between $117.37 and $118.115.
After this sale, Broden directly beneficially owned 122,062 shares of Aflac common stock. In addition, there are 340 shares reported as indirectly owned through his spouse.
Aflac Inc filed a Form 13F reporting institutional holdings. The filing lists 3 information-table entries with a total value of $138,714,822 and notes 1 other included manager, Aflac Asset Management LLC. The report was signed by Robin Blackmon on 02-06-2026.
Aflac Incorporated has a Form 144 notice indicating a planned sale of 13,000 shares of its common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $1,529,646.00 and an approximate sale date of February 6, 2026.
The shares were acquired from the issuer as restricted stock vesting between 2018 and 2021 as compensation, in multiple small grants. The filing notes that 524,113,917 shares of common stock were outstanding, providing scale for the proposed sale.
Aflac Incorporated furnished information about its 2025 fourth quarter and full year 2025 financial results in connection with this current report. The company issued a press release, supplemental financial materials, and an investor presentation, and also provided a video discussion by its Senior Executive Vice President and Chief Financial Officer.
These materials, including the press release, financial supplement, transcript of the CFO’s comments, and presentation slides, are included as exhibits and referenced in full, giving investors multiple formats to review the company’s recent financial performance and commentary.
The Vanguard Group reported a major ownership position in Aflac Inc. common stock. Vanguard beneficially owns 57,141,127 Aflac shares, representing 10.9 % of the outstanding common stock as of the event date. Vanguard has no sole voting power over these shares, but has shared voting power over 3,018,037 shares. It has sole dispositive power over 52,252,431 shares and shared dispositive power over 4,888,696 shares.
The shares are held in the ordinary course of Vanguard’s investment management business, and the filing states they are not held for the purpose of changing or influencing control of Aflac. Vanguard’s clients, including registered investment companies and other managed accounts, have rights to dividends and sale proceeds, and no single other person’s interest exceeds 5 % of the class.
AFLAC Inc. Chairman, CEO and director Daniel P. Amos reported stock gifts involving company common shares. On 12/19/2025, he disposed of 161,175 shares of AFLAC common stock in a transaction coded as a gift at a reported price of
AFL shareholder Steven K Beaver has filed a Rule 144 notice to sell 5,492 shares of the issuer’s common stock through broker LPL Financial, with an approximate sale date of 12/12/2025 on the NYSE. The notice lists an aggregate market value of 601,099.40 for this proposed sale and reports 524,113,917 shares of this class outstanding.
The securities to be sold come from 14,480 common shares acquired from the issuer as vested restricted stock on 02/11/2024, with cash shown as the form of payment dated 12/12/2025. The filing also reports that during the past three months Beaver sold 3,452 common shares on 12/05/2025 for gross proceeds of 377,165.88. By signing, the seller represents that he is not aware of any undisclosed material adverse information about the issuer.
Aflac executive Steven K. Beaver, EVP and CFO of Aflac Japan, reported selling 5,492 shares of Aflac Inc. common stock on 12/12/2025 at a weighted average price of $109.5266 per share, through multiple trades between $109.50 and $109.575. After this transaction, he beneficially owns 38,368 shares of Aflac common stock directly.
Aflac CEO Daniel P. Amos, who also serves as chairman and a director, reported several changes in his Aflac common stock holdings, with the earliest transaction dated 12/12/2025.
Following these transactions, he beneficially owns 742,711 Aflac common shares directly. Indirect holdings include 1,546 shares through his spouse, 3,520 in a spouse IRA, 941,326 through a partnership, and 908,632 as trustee for children. The reported transactions in the table show a price of $0 per share.
Aflac (AFL) insider plans to sell a small block of shares under Rule 144. The notice covers a proposed sale of 5,492 shares of Aflac common stock through broker LPL Financial on the NYSE, with an aggregate market value of $601,099.40 at the time of the filing. The filing notes that 524,113,917 Aflac shares were outstanding, providing context for the relatively small size of this sale. The shares being sold relate to 14,480 shares of vested restricted stock that were acquired from the issuer on 02/11/2024, with cash listed as the form of payment.